Another study investigating the relationship between the sleep–wake cycle impairment and the CSF AD biomarkers and CSF orexin concentrations in mild to moderate AD patients showed a correlation between tau proteins and orexin CSF levels and the sleep–wake cycle dysregulation [66]. Here, MAPT is linked to Alzheimer disease.